Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.47 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.47 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.39 |
| ▸ | CSF1R | P07333 | 1/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.38 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1627177 | 0.95 | LPL (0.51) | LPLLIPGIRAK4CSF1RPRMT5 | |
| SCHEMBL1629562 | 0.95 | LPL (0.51) | LPLLIPGIRAK4CSF1RPRMT5 | |
| SCHEMBL6126262 | 0.93 | LPL (0.53) | LPLLIPGIRAK4CSF1RPRMT5 | |
| SCHEMBL13331252 | 0.91 | LPL (0.43) | LPLLIPGIRAK4CSF1RPRMT5 | |
| SCHEMBL17268981 | 0.90 | LPL (0.56) | LPLLIPGIRAK4PRMT5WDR77 | |
| SCHEMBL25622442 | 0.90 | LPL (0.56) | LPLLIPGIRAK4 | |
| SCHEMBL2261034 | 0.88 | LPL (0.58) | LPLLIPGIRAK4PRMT5WDR77 | |
| SCHEMBL13331256 | 0.87 | LPL (0.45) | LPLLIPGIRAK4CSF1RIDO1 | |
| SCHEMBL13330818 | 0.87 | LPL (0.45) | LPLLIPGIRAK4CSF1RPRMT5 | |
| SCHEMBL10022820 | 0.86 | LPL (0.38) | LPLLIPGIRAK4CSF1RPRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2200104-B1 | Organic light-emitting device | CANON KK (JP) | 2019-09-04 | — | — | EP | disclosed |
| EP-2379473-B1 | DIACENAPHTHO[1,2-B:1',2'-K]CHRYSENE DERIVATIVE | CANON KK (JP) | 2017-02-22 | — | — | EP | disclosed |
| US-8951648-B2 | Diacenaphtho[1,2-b:1′,2′-k]chrysene derivative | CANON KABUSHIKI KAISHA (JP) | 2015-02-10 | — | — | US | disclosed |
| US-8951648-B2 | Diacenaphtho[1,2-b:1′,2′-k]chrysene derivative | CANON KABUSHIKI KAISHA (JP) | 2015-02-10 | — | — | US | disclosed |
| US-8519613-B2 | Organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2013-08-27 | — | — | US | disclosed |
| US-20120085996-A1 | ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2012-04-12 | — | — | US | disclosed |
| US-8102116-B2 | Organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2012-01-24 | — | — | US | disclosed |
| US-8102116-B2 | Organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2012-01-24 | — | — | US | disclosed |
| US-20120013700-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-01-19 | — | — | US | disclosed |
| US-20120013700-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-01-19 | — | — | US | disclosed |
| US-20110251446-A1 | DIACENAPHTHO[1,2-b:1',2'-k]CHRYSENE DERIVATIVE | CANON KABUSHIKI KAISHA (JP) | 2011-10-13 | — | — | US | disclosed |
| US-20110251446-A1 | DIACENAPHTHO[1,2-b:1',2'-k]CHRYSENE DERIVATIVE | CANON KABUSHIKI KAISHA (JP) | 2011-10-13 | — | — | US | disclosed |
| WO-2010116661-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2010-10-14 | — | — | WO | disclosed |
| US-20100157131-A1 | ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100157131-A1 | ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2010-06-24 | — | — | US | disclosed |
| WO-2010071224-A1 | DIACENAPHTHO[1,2-b:1',2'-k]CHRYSENE DERIVATIVE | CANON KABUSHIKI KAISHA (JP) | 2010-06-24 | — | — | WO | disclosed |
| EP-2200104-A2 | Organic light-emitting device | Canon Kabushiki Kaisha (JP) | 2010-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251446-A1 | DIACENAPHTHO[1,2-b:1',2'-k]CHRYSENE DERIVATIVE | DNAJB12, DNAJA1, DNAJA2 | LPL 4849/4885LIPG 4558/4885IRAK4 2692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.